Principal Investigator
Navya Nair
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251180
Clinical Trial Summary
Phase 2 Open-Label Trial Investigating the Efficacy and Safety of Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Gynecologic Cancer
Contact Information
Phone Number
+1 (305) 2434624